Logos Global Management’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112M Sell
3,000,000
-450,000
-13% -$13.8M 4.81% 4
2026
Q1
$115M Buy
3,450,000
+325,000
+10% +$10.9M 5.74% 3
2025
Q4
$108M Buy
3,125,000
+875,000
+39% +$27.9M 6.53% 3
2025
Q3
$61.2M Sell
2,250,000
-1,095,000
-33% -$26.5M 5.49% 2
2025
Q2
$70.3M Sell
3,345,000
-155,000
-4% -$2.97M 7.78% 2
2025
Q1
$57.3M Buy
3,500,000
+500,000
+17% +$10.7M 10.19% 1
2024
Q4
$77.1M Buy
3,000,000
+900,000
+43% +$25.5M 9.02% 1
2024
Q3
$66.5M Buy
2,100,000
+400,000
+24% +$15.2M 7.18% 1
2024
Q2
$59.7M Buy
1,700,000
+200,000
+13% +$7.92M 4.8% 4
2024
Q1
$65.8M Sell
1,500,000
-300,000
-17% -$12.9M 5.33% 3
2023
Q4
$64M Sell
1,800,000
-450,000
-20% -$13.4M 5.98% 3
2023
Q3
$60.7M Buy
2,250,000
+500,000
+29% +$12.7M 8.1% 2
2023
Q2
$41.1M Sell
1,750,000
-1,850,000
-51% -$38M 5.59% 4
2023
Q1
$49.4M Sell
3,600,000
-300,000
-8% -$5M 7.07% 2
2022
Q4
$70.9M Sell
3,900,000
-235,000
-6% -$3.95M 8.3% 1
2022
Q3
$61.7M Buy
4,135,000
+385,000
+10% +$5M 7.58% 3
2022
Q2
$51.8M Buy
3,750,000
+900,000
+32% +$10M 9.49% 3
2022
Q1
$31.9M Buy
2,850,000
+1,300,000
+84% +$19.2M 4.13% 10
2021
Q4
$36.6M Sell
1,550,000
-225,000
-13% -$5.23M 3.78% 10
2021
Q3
$45.2M Buy
+1,775,000
New +$41.4M 3.26% 9

Other funds holding IDYA

Logos Global Management's IDYA Position: Q2 2026 in Review

Logos Global Management reduced its IDEAYA Biosciences (IDYA) stake by 13% in Q2 2026, selling an estimated $13.8M and leaving 3,000,000 shares worth $112M. The position accounts for 4.81% of the portfolio, ranked #4.

Logos Global Management first reported a position in IDYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $115M in Q1 2026. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Logos Global Management held 3,000,000 shares of IDEAYA Biosciences worth $112M as of Q2 2026.
  • Logos Global Management sold 450,000 IDEAYA Biosciences shares in Q2 2026, an estimated $13.8M.
  • IDEAYA Biosciences made up 4.81% of Logos Global Management's portfolio in Q2 2026, its #4 holding.
  • Logos Global Management first reported a position in IDEAYA Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Logos Global Management's IDEAYA Biosciences position peaked at $115M in Q1 2026.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.